Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Head & Neck 1

Conditions

Colorectal Neoplasms 24Neoplasms 12Colonic Neoplasms 12Breast Neoplasms 12Prostatic Neoplasms 9Polycythemia Vera 9Venous Thromboembolism 8Multiple Myeloma 8Recurrence 5Rectal Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Thrombocythemia, Essential 4Ovarian Neoplasms 4Neoplasms, Plasma Cell 4Neoplasm Metastasis 4Myeloproliferative Disorders 4Barrett Esophagus 4Precancerous Conditions 3Melanoma 3Esophageal Neoplasms 3Adenomatous Polyps 3Adenoma 3Tobacco Use Disorder 2Thrombosis 2Thromboembolism 2Smoking Cessation 2Sarcoma 2Primary Myelofibrosis 2Neoplastic Cells, Circulating 2Neoplasms by Site 2

Interventions

Photochemotherapy 3Metformin 3Pioglitazone 2Biopsy 2Aminolevulinic Acid 2Sulindac 1Specimen Handling 1Rosiglitazone 1Photosensitizing Agents 1Nivolumab 1Melatonin 1Gene Expression Profiling 1Fluorouracil 1Dihematoporphyrin Ether 1Dapsone 1Celecoxib 1Aspirin 1Acyclovir 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Leukoplakia, Oral × Aspirin × Clear all
NCT01238185 2013-08-12

Aspirin Mouthwash in Treating Patients With Oral Leukoplakia

National Cancer Institute (NCI)

Phase 1 Completed
40 enrolled
Head & NeckOther neoplasm

Leukoplakia, Oral, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡